These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25348815)

  • 21. Synthesis and evaluation of carbocyanine dyes as PRMT inhibitors and imaging agents.
    Sinha SH; Owens EA; Feng Y; Yang Y; Xie Y; Tu Y; Henary M; Zheng YG
    Eur J Med Chem; 2012 Aug; 54():647-59. PubMed ID: 22749641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nη-substituted arginyl peptide inhibitors of protein arginine N-methyltransferases.
    Lakowski TM; 't Hart P; Ahern CA; Martin NI; Frankel A
    ACS Chem Biol; 2010 Nov; 5(11):1053-63. PubMed ID: 20701328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virtual Screening with a Structure-Based Pharmacophore Model to Identify Small-Molecule Inhibitors of CARM1.
    Ran T; Li W; Peng B; Xie B; Lu T; Lu S; Liu W
    J Chem Inf Model; 2019 Jan; 59(1):522-534. PubMed ID: 30607947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small Molecule Inhibitors of Protein Arginine Methyltransferases.
    Hu H; Qian K; Ho MC; Zheng YG
    Expert Opin Investig Drugs; 2016; 25(3):335-58. PubMed ID: 26789238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of selective protein arginine methyltransferase 5 inhibitors and biological evaluations.
    Ji S; Ma S; Wang WJ; Huang SZ; Wang TQ; Xiang R; Hu YG; Chen Q; Li LL; Yang SY
    Chem Biol Drug Des; 2017 Apr; 89(4):585-598. PubMed ID: 27714957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In situ generation of a bisubstrate analogue for protein arginine methyltransferase 1.
    Osborne T; Roska RL; Rajski SR; Thompson PR
    J Am Chem Soc; 2008 Apr; 130(14):4574-5. PubMed ID: 18338885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of PRMT5 inhibitors with novel scaffold structures through virtual screening and biological evaluations.
    Zhang Q; Zhang L; Jin J; Fan Y; Wang X; Hu H; Ye X; Wang L; Cao C; Ye F
    J Mol Model; 2022 Jun; 28(7):184. PubMed ID: 35680707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of Novel PRMT5 Inhibitors by Virtual Screening and Biological Evaluations.
    Tao H; Yan X; Zhu K; Zhang H
    Chem Pharm Bull (Tokyo); 2019; 67(4):382-388. PubMed ID: 30930442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potent, Selective, and Cell Active Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor Developed by Structure-Based Virtual Screening and Hit Optimization.
    Mao R; Shao J; Zhu K; Zhang Y; Ding H; Zhang C; Shi Z; Jiang H; Sun D; Duan W; Luo C
    J Med Chem; 2017 Jul; 60(14):6289-6304. PubMed ID: 28650658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural basis for CARM1 inhibition by indole and pyrazole inhibitors.
    Sack JS; Thieffine S; Bandiera T; Fasolini M; Duke GJ; Jayaraman L; Kish KF; Klei HE; Purandare AV; Rosettani P; Troiani S; Xie D; Bertrand JA
    Biochem J; 2011 Jun; 436(2):331-9. PubMed ID: 21410432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of 2,4-diphenyl-substituted thiazole derivatives as PRMT1 inhibitors and investigation of their anti-cervical cancer effects.
    Zhao Z; Zhang J; Ren Y; Dong L; Wu H; Hong W; Huang H; Yang X; Pang Z; Wang H
    Bioorg Med Chem; 2023 Sep; 92():117436. PubMed ID: 37556911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases.
    Eram MS; Shen Y; Szewczyk M; Wu H; Senisterra G; Li F; Butler KV; Kaniskan HÜ; Speed BA; Dela Seña C; Dong A; Zeng H; Schapira M; Brown PJ; Arrowsmith CH; Barsyte-Lovejoy D; Liu J; Vedadi M; Jin J
    ACS Chem Biol; 2016 Mar; 11(3):772-781. PubMed ID: 26598975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery and structure-activity analysis of 4-((5-nitropyrimidin-4-yl)amino)benzimidamide derivatives as novel protein arginine methyltransferase 1 (PRMT1) inhibitors.
    Yu XR; Tang Y; Wang WJ; Ji S; Ma S; Zhong L; Zhang CH; Yang J; Wu XA; Fu ZY; Li LL; Yang SY
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5449-53. PubMed ID: 26428871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective small-chemical inhibitors of protein arginine methyltransferase 5 with anti-lung cancer activity.
    Kong GM; Yu M; Gu Z; Chen Z; Xu RM; O'Bryant D; Wang Z
    PLoS One; 2017; 12(8):e0181601. PubMed ID: 28806746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic small molecule modulators of histone and DNA methylation.
    Hauser AT; Robaa D; Jung M
    Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Target-based approach to inhibitors of histone arginine methyltransferases.
    Spannhoff A; Heinke R; Bauer I; Trojer P; Metzger E; Gust R; Schüle R; Brosch G; Sippl W; Jung M
    J Med Chem; 2007 May; 50(10):2319-25. PubMed ID: 17432842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acyl derivatives of p-aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1.
    Bissinger EM; Heinke R; Spannhoff A; Eberlin A; Metzger E; Cura V; Hassenboehler P; Cavarelli J; Schüle R; Bedford MT; Sippl W; Jung M
    Bioorg Med Chem; 2011 Jun; 19(12):3717-31. PubMed ID: 21440447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diamidine compounds for selective inhibition of protein arginine methyltransferase 1.
    Yan L; Yan C; Qian K; Su H; Kofsky-Wofford SA; Lee WC; Zhao X; Ho MC; Ivanov I; Zheng YG
    J Med Chem; 2014 Mar; 57(6):2611-22. PubMed ID: 24564570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential.
    Krause CD; Yang ZH; Kim YS; Lee JH; Cook JR; Pestka S
    Pharmacol Ther; 2007 Jan; 113(1):50-87. PubMed ID: 17005254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical probes for protein arginine methyltransferases.
    Li ASM; Li F; Eram MS; Bolotokova A; Dela Seña CC; Vedadi M
    Methods; 2020 Mar; 175():30-43. PubMed ID: 31809836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.